Seattle, WA, United States of America

Ajamete Kaykas

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ajamete Kaykas: Advancements in Immunological Treatments

Introduction: Ajamete Kaykas is an accomplished inventor based in Seattle, WA, renowned for his significant contributions to the field of immunology. With two patents to his name, Kaykas has made noteworthy strides in developing therapeutic approaches that address various immunological diseases and disorders.

Latest Patents: Kaykas' latest patents focus on groundbreaking compositions and methodologies. His first patent involves CD47 related compositions and methods for treating immunological diseases and disorders. This invention details fusion polypeptides that feature a CD47 extracellular domain or a variant fused to an Fc polypeptide. These fusion polypeptides are instrumental in suppressing immunoresponsiveness of immune cells and inhibiting the production of proinflammatory cytokines, thereby providing new avenues for treatment. Additionally, his second patent outlines methods for identifying viral virulence factors and cellular polypeptides that interact with these viral proteins. This method holds promise for discovering therapeutic targets for treating immunological ailments.

Career Highlights: Ajamete Kaykas has pursued a remarkable career and has been associated with prestigious institutions. Notably, he worked with the Board of Trustees of the Leland Stanford Junior University, where he likely cultivated his research interests and innovative spirit. Kaykas also made his mark at Viral Logic Systems Technology Corporation, collaborating on advanced projects that target immunological challenges.

Collaborations: Throughout his career, Kaykas has partnered with distinguished coworkers such as Craig A. Smith and Steven R. Wiley. These collaborations have undoubtedly enriched his work, fostering a productive environment for scientific exploration and innovation.

Conclusion: Ajamete Kaykas continues to be a vital force in the realm of immunological research. His recent patents open up exciting possibilities for novel treatments, underscoring the impact of innovation in medical science. As he progresses in his endeavors, the contributions of Kaykas are sure to inspire future breakthroughs in the treatment of immunological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…